{"name": "Xenome",
 "permalink": "xenome",
 "crunchbase_url": "http://www.crunchbase.com/company/xenome",
 "homepage_url": "http://www.xenome.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "enquiries@xenome.com",
 "phone_number": "61-7-3720-8055",
 "description": "",
 "created_at": "Mon Mar 15 06:36:22 UTC 2010",
 "updated_at": "Thu Sep 02 08:46:34 UTC 2010",
 "overview": "\u003Cp\u003EXenome is a progressive Australian biotechnology company with a promising and distinctive technology platform targeting pain and inflammation.  Xen2174, the Company\u0026#8217;s lead drug candidate is currently completing a Phase 1b/2a clinical trial for cancer pain with evidence to date providing strong support that the trial endpoints will be successfully met.  More substantive clinical trials for expanded indications are planned for 2008.  In addition, the drug discovery platform from which Xen2174 emerged has inherent value due to its ability to repeatedly identify new lead medicinal compounds on the basis of its unique construction around Australian biodiversity.  Specifically, Xenome has generated a unique expertise in peptide chemistry to translate the evolutionary advantages inherent in venom peptides into highly bioactive libraries of molecules that are of interest to global biotechnology and pharmaceutical companies. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       65],
      "assets/images/resized/0008/0338/80338v1-max-150x150.jpg"],
     [[206,
       90],
      "assets/images/resized/0008/0338/80338v1-max-250x250.jpg"],
     [[206,
       90],
      "assets/images/resized/0008/0338/80338v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$22.5M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.xenome.com/v2/index.php?menu=news_full\u0026id=52\u0026year=news_2007",
    "source_description": "Xenome Receives a syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment  Partners.",
    "raised_amount": 10000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 11,
    "funded_day": 27,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "QIC BioVentures",
         "permalink": "qic-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               65],
              "assets/images/resized/0008/0341/80341v1-max-150x150.jpg"],
             [[193,
               84],
              "assets/images/resized/0008/0341/80341v1-max-250x250.jpg"],
             [[193,
               84],
              "assets/images/resized/0008/0341/80341v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Amylin Pharmaceuticals",
         "permalink": "amylin-pharmaceuticals",
         "image":
          {"available_sizes":
            [[[142,
               63],
              "assets/images/resized/0006/0118/60118v1-max-150x150.png"],
             [[142,
               63],
              "assets/images/resized/0006/0118/60118v1-max-250x250.png"],
             [[142,
               63],
              "assets/images/resized/0006/0118/60118v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Innovis Investments",
         "permalink": "innovis-investments",
         "image": null},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.xenome.com/v2/index.php?menu=news_full\u0026id=91\u0026year=news_2010",
    "source_description": "Xenome Completes A$10M Convertible Note Financing: Ongoing Support from Existing Venture Capital Investors - 22 April 2010",
    "raised_amount": 10000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 22,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "QIC BioVentures",
         "permalink": "qic-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               65],
              "assets/images/resized/0008/0341/80341v1-max-150x150.jpg"],
             [[193,
               84],
              "assets/images/resized/0008/0341/80341v1-max-250x250.jpg"],
             [[193,
               84],
              "assets/images/resized/0008/0341/80341v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "GBS Ventures",
         "permalink": "gbs-ventures",
         "image":
          {"available_sizes":
            [[[100,
               74],
              "assets/images/resized/0004/8580/48580v1-max-150x150.png"],
             [[100,
               74],
              "assets/images/resized/0004/8580/48580v1-max-250x250.png"],
             [[100,
               74],
              "assets/images/resized/0004/8580/48580v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.xenome.com/v2/index.php?menu=news_full\u0026id=37\u0026year=news_2005",
    "source_description": "Xenome - Funding",
    "raised_amount": 2500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 4,
    "funded_day": 6,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "QIC BioVentures",
         "permalink": "qic-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               65],
              "assets/images/resized/0008/0341/80341v1-max-150x150.jpg"],
             [[193,
               84],
              "assets/images/resized/0008/0341/80341v1-max-250x250.jpg"],
             [[193,
               84],
              "assets/images/resized/0008/0341/80341v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "120 Meiers Rd, Indooroopilly",
    "address2": "Queensland",
    "zip_code": "4068",
    "city": "",
    "state_code": null,
    "country_code": "AUS",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        104],
       "assets/images/resized/0008/0339/80339v1-max-150x150.jpg"],
      [[250,
        174],
       "assets/images/resized/0008/0339/80339v1-max-250x250.jpg"],
      [[450,
        314],
       "assets/images/resized/0008/0339/80339v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}